Conservative management versus aspiration of functional ovarian cysts before ovarian stimulation for assisted reproduction
- PMID: 10976412
- PMCID: PMC3455200
- DOI: 10.1023/a:1009406315729
Conservative management versus aspiration of functional ovarian cysts before ovarian stimulation for assisted reproduction
Abstract
Purpose: To compare the efficiency of transvaginal ultrasound-guided functional ovarian cyst aspiration, with conservative management, in the outcome of patients undergoing assisted reproductive technique (ART) (in vitro fertilization or intracytoplasmic sperm injection). These cysts were identified before ovarian stimulation begun and after administration of a midluteal GnRH agonist.
Methods: Fifty nine patients undergoing ART from January 1, 1997 to February 28, 1999, who developed functional ovarian cysts were included. Aspirations of these cysts (n = 14) versus conservative management (observation) (n = 45) were compared. Total number of ovarian follicles developed, number of oocytes retrieved, estradiol levels on the day of human chorionic gonadotropin, fertilization rate, number of good quality embryos transferred, implantation, and clinical pregnancy rate per cycle were evaluated.
Results: No statistical differences were observed between the two groups in any of the selected parameters.
Conclusions: Cyst aspiration and conservative management showed similar implantation and pregnancy rates, in patients who develop functional ovarian cysts after pituitary down-regulation following luteal phase gonadotropin-releasing hormone agonist administration. Prospective studies are needed to confirm this trend.
Similar articles
-
Comparative study on the pregnancy outcomes of in vitro fertilization-embryo transfer between long-acting gonadotropin-releasing hormone agonist combined with transvaginal ultrasound-guided cyst aspiration and long-acting gonadotropin-releasing hormone agonist alone.Contemp Clin Trials. 2012 Nov;33(6):1206-10. doi: 10.1016/j.cct.2012.07.009. Epub 2012 Jul 20. Contemp Clin Trials. 2012. PMID: 22820320 Clinical Trial.
-
Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.J Clin Endocrinol Metab. 2003 Sep;88(9):4186-92. doi: 10.1210/jc.2002-021953. J Clin Endocrinol Metab. 2003. PMID: 12970285 Clinical Trial.
-
Ovarian cyst formation following GnRH agonist administration in IVF cycles: incidence and impact.Hum Reprod. 2006 Mar;21(3):640-4. doi: 10.1093/humrep/dei371. Epub 2005 Oct 27. Hum Reprod. 2006. PMID: 16253965
-
Determination of the efficiency of controlled ovarian hyperstimulation in the gonadotropin-releasing hormone agonist-suppression cycle using the initial follicle count during gonadotropin stimulation.J Assist Reprod Genet. 2001 Feb;18(2):91-6. doi: 10.1023/a:1026582608645. J Assist Reprod Genet. 2001. PMID: 11285987 Free PMC article.
-
The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.Fertil Steril. 2008 Jan;89(1):84-91. doi: 10.1016/j.fertnstert.2007.02.002. Epub 2007 Apr 26. Fertil Steril. 2008. PMID: 17462639 Clinical Trial.
Cited by
-
Ovarian Cyst Formation Following Gonadotropin-Releasing Hormone-Agonist Administration Decreases the Oocyte Quality in IVF Cycles.Balkan Med J. 2012 Jun;29(2):197-200. doi: 10.5152/balkanmedj.2011.019. Epub 2012 Jun 1. Balkan Med J. 2012. PMID: 25206994 Free PMC article.
-
Functional Ovarian Cysts in Artificial Frozen-Thawed Embryo Transfer Cycles With Depot Gonadotropin-Releasing Hormone Agonist.Front Endocrinol (Lausanne). 2022 Apr 29;13:828993. doi: 10.3389/fendo.2022.828993. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35574002 Free PMC article.
-
Ovarian cyst aspiration prior to in vitro fertilization treatment for subfertility.Cochrane Database Syst Rev. 2014;2014(12):CD005999. doi: 10.1002/14651858.CD005999.pub2. Epub 2014 Dec 12. Cochrane Database Syst Rev. 2014. PMID: 25502626 Free PMC article.
References
-
- Porter RN, Smith W, Craft IL, Abdulwahid NA, Jacobs HS. Induction of ovulation for in-vitro fertilization using buserelin and gonadotropins. Lancet. 1984;2:1284–1285. - PubMed
-
- Waegemaekers CT, Van-de-Berg A, Helmerhorst FM, Naaktgeborn N. Ovarian cyst formation during the use of GnRH analogue in an IVF program. Acta Eur Fertil. 1987;18:411–417. - PubMed
-
- Feldberg D, Ashkenazi J, Dicker D, Yeshaya A, Goldman GA, Goldman JA. Ovarian cyst formation: A complication of gonadotropin-releasing hormone agonist therapy. Fertil Steril. 1989;51:42–45. - PubMed
-
- Herman A, Ron-El R, Golan A, Nahum H, Soffer Y, Caspi E. Follicle cyst after menstrual versus midluteal administration of gonadotropin-releasing hormone analog in in vitro fertilization. Fertil Steril. 1990;53:854–858. - PubMed
-
- Jenkins JM, Anthony FW, Wood P, Rushen D, Masson GM, Thomas E. The development of functional ovarian cysts during pituitary down-regulation. Hum Reprod. 1993;8:1623–1627. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical